Our SITE 2026 symposium explored peripheral lesion management, from complex endovascular procedures to flexion-zone and BTK treatment. Thanks to Dr. Vincente Riambau, Dr. Lieven Maene and Dr. Bruno Migliara for sharing their insights on iCover, iVolution pro and Luminor DCB.

We and our partner Thang Long Medical Equipment have participated at the 20th National Cardiology Congress #VNCC2026 in Da Nang, Vietnam. The event helped us connect with local coronary specialists and strengthen our presence. Thank you to the team for their continued support.

Let’s connect at EuroSwissCTO 2026! Join us from October 14–16 to exchange insights on the challenges of treating chronic total occlusions and discover how innovative solutions such as Naviscore can support complex coronary interventions. Visit us at Booth 18 and meet our team!

Our APAC Distributor Meeting brought together partners from across the region to align on strategy, share business and portfolio updates, and identify new growth opportunities. Thank you to all our distributors for your dedication, expertise, and continued trust in iVascular.

Our partner Vas Innovative represented iVascular at the Basic to Mastery Course of Aortoiliac Disease 2026 in Thailand, bringing together vascular surgery fellows and professionals for hands-on training and endovascular discussions. Thank you for you continued collaboration!

The 2nd iLumina edition has ended! iLumina is a multidisciplinary course focused on AV fistula with the objective to offer dialysis patients the best care. Thank you Prof. Matteo Tozzi, the team and our 10 attendees worldwide for sharing their experiences.

Our achievements are built by people, and they deserve to be celebrated. A day to leave routines behind, come together, celebrate what we have achieved, and recognize the people behind every milestone. This is iVascular. And this is the team behind it. #iVascular #Team

Great to connect with the endovascular community at #CIET2026 in Singapore. Together with our partner Alcare, we shared our peripheral portfolio with vascular specialists from across the region, with strong interest in our solutions and their clinical applications.

At CIRSE 2026, Dr. Bahaa Nasr presented the 1-year outcomes of the iliCo study, showing strong results for iCover in aortoiliac occlusive disease, with 96.7% fTLR and patient clinical improvement of 90.4%. #CIRSE2026 #iCover #AortoiliacDisease #ClinicalEvidence

Dr. Fernando Gómez presented, for the first time, the results of the OPAL premarket study evaluating Amber Liquid Embolic at #CIRSE2026. In 70 patients, complete occlusion was achieved in 98% of procedures, highlighting the strong performance of Amber. #CIRSE2026 #Amber

LUMIFOLLOW at #CIRSE2026. Presented by Dr. Sara Sedillot-Daniel (France), new 3-year data reinforce the safety and efficacy of Luminor DCB in femoropopliteal lesions (88.3% fTLR), with sustained clinical benefit over time. #iVascular #LuminorDCB #CIRSE2026

We’re at CIRSE 2026! Our team is ready to welcome you in Copenhagen. Visit us at Booth D49 to discover our solutions, exchange experiences with our team and explore how we can support your daily clinical practice. 📍 Booth D49 | CIRSE 2026 #CIRSE2026 #iVascular #Endovascular

What advantages could iCover offer as a bridging stent in FEVAR? Dr. Eric Ducasse, PI of the #fenCo study, shares his expectations on iCover’s performance, highlighting its potential for technical success, long-term patency, and durable outcomes in complex aortic anatomies.

We toke part in MATCH ONLINE 2026, bringing together vascular specialists across Asia to exchange experience in PAD management and endovascular treatment. Thanks to HeartCare Medical, the faculty and all participants for making this valuable educational initiative possible.

At iVascular, every product is designed, developed, and manufactured entirely in our European facilities. End-to-end in-house production gives us full control over every step, ensuring quality, consistency, and innovation that our partners can rely on.